550-551 / 1676
Heterogeneity
•
The results loose credibility
•
Different effect sizes in different trials
•
Different patient cohorts?
•
Different treatment efficacy?
•
Quality of data
- How often is the TSH measured?
- In Hodgkin patients?
- In H&NSCC patients?
•
An opportunity to learn
•
Which patients benefit?
•
Which is the better treatment?